Zacks Research Issues Negative Outlook for Teleflex Earnings

Teleflex Incorporated (NYSE:TFX) – Equities researchers at Zacks Research decreased their Q1 2025 earnings per share (EPS) estimates for shares of Teleflex in a research note issued to investors on Thursday, March 6th. Zacks Research analyst R. Department now anticipates that the medical technology company will earn $2.77 per share for the quarter, down from their prior forecast of $3.51. The consensus estimate for Teleflex’s current full-year earnings is $13.98 per share. Zacks Research also issued estimates for Teleflex’s FY2025 earnings at $14.04 EPS, Q1 2026 earnings at $3.45 EPS and FY2026 earnings at $14.97 EPS.

Several other equities research analysts also recently commented on TFX. Morgan Stanley lowered their target price on shares of Teleflex from $275.00 to $191.00 and set an “overweight” rating for the company in a research note on Wednesday, March 5th. Wells Fargo & Company dropped their price objective on Teleflex from $214.00 to $146.00 and set an “equal weight” rating on the stock in a research note on Friday, February 28th. Citizens Jmp lowered Teleflex from an “outperform” rating to a “market perform” rating in a report on Thursday, February 27th. Needham & Company LLC restated a “hold” rating on shares of Teleflex in a report on Monday, December 16th. Finally, Piper Sandler reiterated a “neutral” rating and set a $140.00 price objective (down previously from $255.00) on shares of Teleflex in a report on Friday, February 28th. One analyst has rated the stock with a sell rating, nine have given a hold rating and two have given a buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $182.63.

Teleflex Stock Performance

Shares of NYSE:TFX opened at $140.24 on Monday. The firm’s 50 day simple moving average is $171.13 and its 200 day simple moving average is $201.04. Teleflex has a fifty-two week low of $128.55 and a fifty-two week high of $249.90. The company has a market capitalization of $6.50 billion, a price-to-earnings ratio of 27.88, a P/E/G ratio of 1.73 and a beta of 1.21. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.42 and a quick ratio of 1.39.

Teleflex (NYSE:TFX) last released its quarterly earnings data on Thursday, February 27th. The medical technology company reported $3.89 EPS for the quarter, beating analysts’ consensus estimates of $3.86 by $0.03. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. The business had revenue of $795.40 million during the quarter, compared to the consensus estimate of $813.24 million.

Hedge Funds Weigh In On Teleflex

A number of large investors have recently bought and sold shares of TFX. Apollon Wealth Management LLC lifted its position in shares of Teleflex by 3.7% in the third quarter. Apollon Wealth Management LLC now owns 1,524 shares of the medical technology company’s stock worth $377,000 after purchasing an additional 55 shares in the last quarter. SRS Capital Advisors Inc. lifted its position in Teleflex by 0.3% during the 3rd quarter. SRS Capital Advisors Inc. now owns 19,587 shares of the medical technology company’s stock worth $4,844,000 after buying an additional 60 shares in the last quarter. Janney Montgomery Scott LLC boosted its stake in shares of Teleflex by 0.4% during the 3rd quarter. Janney Montgomery Scott LLC now owns 15,332 shares of the medical technology company’s stock worth $3,792,000 after buying an additional 65 shares during the last quarter. Tokio Marine Asset Management Co. Ltd. grew its holdings in shares of Teleflex by 4.5% in the 3rd quarter. Tokio Marine Asset Management Co. Ltd. now owns 1,517 shares of the medical technology company’s stock valued at $375,000 after acquiring an additional 66 shares in the last quarter. Finally, HighTower Advisors LLC increased its position in shares of Teleflex by 1.7% in the third quarter. HighTower Advisors LLC now owns 3,998 shares of the medical technology company’s stock valued at $986,000 after acquiring an additional 66 shares during the last quarter. Institutional investors and hedge funds own 95.62% of the company’s stock.

Teleflex Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Monday, March 17th. Investors of record on Friday, March 7th will be given a $0.34 dividend. This represents a $1.36 dividend on an annualized basis and a yield of 0.97%. The ex-dividend date is Friday, March 7th. Teleflex’s dividend payout ratio is presently 95.77%.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.